We believe that the possible causes are the disruption of the transcription factor network by end-stage liver disease which leads to an incomplete correction of the numerous effector molecules regulated by HNF4α, or the occurrence of some negative feedback pathway because HPCs amplification exacerbates liver fibrosis, the exact mechanism of which remains to be investigated. The gene discussed is HNF4A; the disease is Hepatic fibrosis.